semaglutide base compound Compounded Weight Management Program As Ozempic demand climbs, patients

Neuroreport 35 (3), 143151

doi: 10.1007/s12272-025-01542-4 48

After neuroscientist Martha Bagnall read a recent New Yorker article about Ozempic the buzzy celebrity weight loss jab thats upending obesity medicine she emailed a colleague to dish on what she felt were gaps in the discussion about the drugs effects on the brain

& Landry, J

Each reshaped medicine, but also brought unintended consequences: overprescribing, affordability crises, and backlash when the costs or risks became undeniable

You see the same board-certified providers, follow the same protocols, and receive the same level of personalized attention